This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Sep;7(9):478.

doi: 10.1038/nrcardio.2010.114.

Antiplatelet therapy: Long-term dual antiplatelet therapy and bleeding in stable patients--insights from CHARISMA

PMID: 20806464
DOI: 10.1038/nrcardio.2010.114

Comment

Antiplatelet therapy: Long-term dual antiplatelet therapy and bleeding in stable patients--insights from CHARISMA

Joana Osório. Nat Rev Cardiol. 2010 Sep.

. 2010 Sep;7(9):478.

doi: 10.1038/nrcardio.2010.114.

Author

PMID: 20806464
DOI: 10.1038/nrcardio.2010.114

No abstract available

PubMed Disclaimer

Comment on

Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Berger PB, Bhatt DL, Fuster V, Steg PG, Fox KA, Shao M, Brennan DM, Hacke W, Montalescot G, Steinhubl SR, Topol EJ; CHARISMA Investigators. Berger PB, et al. Circulation. 2010 Jun 15;121(23):2575-83. doi: 10.1161/CIRCULATIONAHA.109.895342. Epub 2010 Jun 1. Circulation. 2010. PMID: 20516378 Clinical Trial.

References

1. Circulation. 2010 Jun 15;121(23):2575-83 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.